Objective Measurement in Clinical Care of Patients with Parkinson’s disease: an RCT using the PKG
Objective: To use the Parkinson’s KinetiGraph™ (Global Kinetics CorporationTM, Australia) to help identify uncontrolled Parkinson’s disease (PD) symptoms and assist changes in clinical management leading…Autonomous Tracking of Body Bradykinesia during Unconstrained Activities in Parkinson’s Disease
Objective: To develop an algorithm for real-time automated detection of body bradykinesia during unconstrained activities using combined inertial measurement (IMU) and electromyographic (EMG) sensor data.…A Service Evaluation of the Clinical Use of Parkinson’s KinetiGraph (PKG) Movement Recording System in the Assessment of Parkinson’s Disease Patients with Tremor
Objective: To evaluate the clinical usefulness of PKG Movement Recording System in the assessment process to aid recognition and understanding of tremor in patients with Parkinson’s disease…Objective measurement of upper extremity bradykinesia using the keyboard-based dexterity test
Objective: To objectively assess the bradykinesia of upper extremity using the Objective Movement Disorder Measurement (OMDM)-Dexterity test Background: Bradykinesia is one of the clinical hallmarks…Segregation of subjective and objective clinical measures in Parkinson’s disease
Objective: Use standardized measures to characterize disease severity, progression, and outcomes in Parkinson’s disease (PD). Background: Subjective and objective standardized measures are usually performed in…Neural correlates of movement sequence kinematics in substantia nigra dopaminergic cells
Objective: To develop a new behavioral task for assessment of mice forelimb movements, and evaluate the substantia nigra pars compacta dopaminergic cells’ (SNpc) correlates of…Effect of object size and obstacle avoidance on of Reach-to-Grasp Actions in Individuals with Parkinson’s disease
Objective: To investigate the effect of object size and obstacle on reach-to-grasp (RTG) actions in individuals Parkinson's disease (PD). Background: Previous studies reported impairments of…Death in patients with Parkinson’s disease – an observational study
Objective: We aimed to analyse the major cause and contributory reasons for death in patients with Parkinson’s disease (PD) who were known to our PD…Noladin ether attenuates MPTP -induced motor deficit by abrogating pro-inflammatory cytokines and striatal neurochemical alterations in rats
Objective: The present study was designed to investigate the therapeutic potential of noladin ether- a putative endocannabinoid against MPTP-induced behavioral, biochemical and neurochemical alterations in…Ambulatory movement measurement in evaluating deep brain stimulation effect in patients with advanced Parkinson’s disease
Objective: To assess the use of the Parkinson's Kinetigraph™ (PKG™) in evaluating the effect of deep brain stimulation (DBS) in patients with advanced Parkinson's disease (PD). Background: Assessment of the effect of DBS on bradykinesia…
- « Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- …
- 24
- Next Page »